These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10927172)

  • 1. Biological chemistry and clinical potential of S-nitrosothiols.
    Hogg N
    Free Radic Biol Med; 2000 May; 28(10):1478-86. PubMed ID: 10927172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
    Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
    Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
    Kowaluk EA; Fung HL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of nitric oxide release from S-nitrosothiols.
    Singh RJ; Hogg N; Joseph J; Kalyanaraman B
    J Biol Chem; 1996 Aug; 271(31):18596-603. PubMed ID: 8702510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical studies of S-nitrosothiols.
    Hou Y; Wang J; Arias F; Echegoyen L; Wang PG
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3065-70. PubMed ID: 9873677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione.
    Askew SC; Butler AR; Flitney FW; Kemp GD; Megson IL
    Bioorg Med Chem; 1995 Jan; 3(1):1-9. PubMed ID: 8612040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyco-S-nitrosothiols: sugar-SNAP, a new type of nitric oxide donor.
    Hou Y; Wang JQ; Ramirez J; Wang PG
    Methods Enzymol; 1999; 301():242-9. PubMed ID: 9919573
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of creatine kinase by S-nitrosothiols: S-nitrosation vs. S-thiolation.
    Konorev EA; Kalyanaraman B; Hogg N
    Free Radic Biol Med; 2000 Jun; 28(11):1671-8. PubMed ID: 10938464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-nitrosothiols and role of metal ions in decomposition to nitric oxide.
    Williams DL
    Methods Enzymol; 1996; 268():299-308. PubMed ID: 8782596
    [No Abstract]   [Full Text] [Related]  

  • 10. New chemical and biological aspects of S-nitrosothiols.
    Wang K; Zhang W; Xian M; Hou YC; Chen XC; Cheng JP; Wang PG
    Curr Med Chem; 2000 Aug; 7(8):821-34. PubMed ID: 10828289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel family of S-nitrosothiols: chemical synthesis and biological actions.
    Al-Sa'doni HH; Khan IY; Poston L; Fisher I; Ferro A
    Nitric Oxide; 2000 Dec; 4(6):550-60. PubMed ID: 11139363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
    Miller MR; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ; Megson IL
    Eur J Pharmacol; 2000 Nov; 408(3):335-43. PubMed ID: 11090652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
    Freedman JE; Frei B; Welch GN; Loscalzo J
    J Clin Invest; 1995 Jul; 96(1):394-400. PubMed ID: 7615810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
    Sogo N; Campanella C; Webb DJ; Megson IL
    Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxynitrite-mediated vasorelaxation: evidence against the formation of circulating S-nitrosothiols.
    Graves JE; Lewis SJ; Kooy NW
    Am J Physiol; 1998 Mar; 274(3):H1001-8. PubMed ID: 9530214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols.
    Hou Y; Guo Z; Li J; Wang PG
    Biochem Biophys Res Commun; 1996 Nov; 228(1):88-93. PubMed ID: 8912640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-nitrosothiols: chemistry, biochemistry, and biological actions.
    Upchurch GR; Welch GN; Loscalzo J
    Adv Pharmacol; 1995; 34():343-9. PubMed ID: 8562444
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of S-nitrosothiols and nitrate tolerance in the rat gastric fundus.
    Barbier AJ; Lefebvre RA
    Br J Pharmacol; 1994 Apr; 111(4):1280-6. PubMed ID: 8032615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.